(Updated - March 18, 2024 2:54 PM EDT)Mizuho analyst Graig Suvannavejh downgraded Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) from Buy to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE